Irish journal of medical science
-
Observational Study
Prevalence of cardiac involvement in home-based recovered coronavirus disease 2019 (COVID-19) patients: a retrospective observational study.
Coronavirus disease 2019 (COVID-19) has a risk of cardiac arrhythmia, acute coronary syndrome, heart failure and myocarditis, and the prognosis of COVID-19 has been associated with cardiovascular symptoms. However, there has not been enough information about cardiovascular involvement in patients who had recovered home-based mild symptoms of COVID-19 infection. Therefore, this study evaluates the prevalence of cardiac involvement and associated factors in home-based recovered COVİD-19 patients. ⋯ We demonstrate cardiac involvement in 46 patients (71%) with recent COVID-19, independent of pre-existing conditions. This indicates that there may be widespread cardiac involvement without high troponin values or severe clinical symptoms.
-
Posterior sternoclavicular dislocations are common in younger patients and are frequently due to high energy sporting incidents. ⋯ We believe this novel technique is safer than the existing described techniques, and it does not compromise on functional outcomes.
-
Contemporary discourse on Artificial Intelligence (AI) in medicine is oft-sensationalised to the point of bearing no resemblance to its everyday impact and potential - either to proselytise it as a saviour or to condemn its perilous, amoral and sprawling reach.This report aims to unravel the paucity of understanding underpinning this hyperbolic duality, whilst addressing the potential clearly defining its ethical use poses to the semi-public healthcare models in Ireland and Europe. ⋯ This report concludes that balanced assessment of AI's role in healthcare requires improvement in three areas: improving clarity in definition of AI and its extant remit in medicine; aligning contemporary discourse on AI use with contemporary objective ethical, legal and system frameworks; and clearly identifying for dismissal a number of logical fallacies deliberately sensationalising AI's potential.
-
Review Case Reports
Gone in 60 days: our first experience with a bioconvertible IVC filter.
The Sentry bioconvertible IVC filter (Boston Scientific, MA, USA) contains a bioabsorbable filament which hydrolyses after 60 days, allowing the arms of the filter to spring open, retract into the vessel wall and endothelialise, leaving an unobstructed IVC lumen. It is a novel treatment option for patients at transient risk of pulmonary emboli with a contraindication to anticoagulation. The device provides similar protection to other currently available devices against pulmonary emboli with minimal complications. ⋯ We review the literature which underpins the development of the bioconvertible filter. We describe our first deployment of the filter in an 85-year-old female with gastric malignancy (who subsequently underwent a subtotal gastrectomy) with a history of anaemia and previous pulmonary emboli. The availability of a bioconvertible filter constitutes a further step forward in the management of patients with potential or active thromboembolic disease.